Misplaced Pages

Regavirumab

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Monoclonal antibody Pharmaceutical compound
Regavirumab
Monoclonal antibody
TypeWhole antibody
SourceHuman
Targetcytomegalovirus glycoprotein B
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
  (what is this?)  (verify)

Regavirumab is a human monoclonal antibody against infections with cytomegalovirus.

References

  1. Arizono H, Sugano T, Kaida S, Shibusawa K, Karasawa Y, Esumi Y, et al. (July 1994). "Pharmacokinetics of a new human monoclonal antibody against cytomegalovirus. Third communication: correspondence of the idiotype activity and virus neutralization activity of the new monoclonal antibody, regavirumab in rat serum and its pharmacokinetics in rats and monkeys". Arzneimittel-Forschung. 44 (7): 909–13. PMID 7945531.
Monoclonal antibodies for infectious disease and toxins
Fungal
Human
Viral
Human
Chimeric
Humanized
Bacterial
Human
Mouse
Chimeric
Humanized
Toxin
Human
Chimeric
Humanized
Stub icon

This antiinfective drug article is a stub. You can help Misplaced Pages by expanding it.

Stub icon

This monoclonal antibody–related article is a stub. You can help Misplaced Pages by expanding it.

Categories: